These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37086493)

  • 21. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
    Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
    Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
    Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
    Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
    Zhang C; Cai Q; Ke J
    Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
    Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrated PSMA1 expression associated with clinicopathological features and prognosis in oral squamous cell carcinoma.
    Rukmini D; Kannan B; Pandi C; Pandi A; Prasad P; Jayaseelan VP; Arumugam P
    Odontology; 2024 Jul; 112(3):950-958. PubMed ID: 38216818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of Synuclein-
    Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
    Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
    Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
    Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
    Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
    Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of potential biomarkers and survival analysis for oral squamous cell carcinoma: A transcriptomic study.
    de Paula Souza DPS; Dos Reis Pereira Queiroz L; de Souza MG; de Jesus SF; Gomes ESB; Vitorino RT; Santos SHS; Farias LC; de Paula AMB; D'Angelo MFSV; de Carvalho Fraga CA; Guimarães ALS
    Oral Dis; 2023 Oct; 29(7):2658-2666. PubMed ID: 35796645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
    Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
    J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma.
    Zheng Y; Fei H
    Biomed Res Int; 2022; 2022():4731364. PubMed ID: 36567912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
    Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
    J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
    Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
    Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
    Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
    Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
    Liu H; Zhang H; Fan H; Tang S; Weng J
    Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.